Prize fund for new antibiotics could mean true innovation
A few weeks ago, a group of Democrats in both houses of Congress introduced the Improving Access to Affordable Prescription Drugs Act, a 129-page bill designed to lower drug prices while increasing innovation and cracking down on pharmaceutical company abuses (my thoughts on the bill are here).
There’s one provision that hasn’t gotten enough attention: the creation of a prize fund for new antibiotics. [...]
Note: this article is behind a paywell. Click here to access the full article.